Ever-changing landscape of biosimilars in canada; findings and implications from a global perspective

Brian Godman; Eleonora Allocati; Evelien Moorkens

doi:10.5639/gabij.2019.0803.012

Ever-changing landscape of biosimilars in canada; findings and implications from a global perspective

Brian Godman^*, Eleonora Allocati, Evelien Moorkens

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

Siu et al. c omprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications. The current situation in Canada is compared with similar initiatives across different countries to enhance savings from biosimilars to improve the affordability of biologicals.

Original language	English
Pages (from-to)	93-97
Number of pages	5
Journal	GaBI Journal
Volume	8
Issue number	3
DOIs	https://doi.org/10.5639/gabij.2019.0803.012
Publication status	Published - 2019
Externally published	Yes

Access to Document

10.5639/gabij.2019.0803.012

Cite this

@article{c8f8c18063e441e0975d15e211eb76cd,

title = "Ever-changing landscape of biosimilars in canada; findings and implications from a global perspective",

abstract = "Siu et al. c omprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications. The current situation in Canada is compared with similar initiatives across different countries to enhance savings from biosimilars to improve the affordability of biologicals.",

author = "Brian Godman and Eleonora Allocati and Evelien Moorkens",

note = "Publisher Copyright: Copyright {\textcopyright} 2019 Pro Pharma Communications International",

year = "2019",

doi = "10.5639/gabij.2019.0803.012",

language = "English",

volume = "8",

pages = "93--97",

journal = "GaBI Journal",

issn = "2033-6403",

publisher = "Pro Pharma Communications International",

number = "3",

}

TY - JOUR

T1 - Ever-changing landscape of biosimilars in canada; findings and implications from a global perspective

AU - Godman, Brian

AU - Allocati, Eleonora

AU - Moorkens, Evelien

PY - 2019

Y1 - 2019

N2 - Siu et al. c omprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications. The current situation in Canada is compared with similar initiatives across different countries to enhance savings from biosimilars to improve the affordability of biologicals.

AB - Siu et al. c omprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications. The current situation in Canada is compared with similar initiatives across different countries to enhance savings from biosimilars to improve the affordability of biologicals.

UR - http://www.scopus.com/inward/record.url?scp=85101152822&partnerID=8YFLogxK

U2 - 10.5639/gabij.2019.0803.012

DO - 10.5639/gabij.2019.0803.012

M3 - Article

AN - SCOPUS:85101152822

SN - 2033-6403

VL - 8

SP - 93

EP - 97

JO - GaBI Journal

JF - GaBI Journal

IS - 3

ER -

Ever-changing landscape of biosimilars in canada; findings and implications from a global perspective

Abstract

Access to Document

Other files and links

Fingerprint

Cite this